Radiation therapy for lymph node metastases from hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 90, 2009, Pages 476-480

  Toya, Ryo ^a   Murakami, Ryuji ^a   Yasunaga, Tadamasa ^b   Baba, Yuji ^c   Nishimura, Ryuichi ^a   Morishita, Shoji ^a   Nishi, Junko ^a   Beppu, Toru ^d   Baba, Hideo ^d   Yamashita, Yasuyuki ^a   Oya, Natsuo ^a  

^a department of Radiation Oncology ^*  (Japan)

^b KUMAMOTO CITY HOSPITAL   (Japan)

^c JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^d KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Local control; Lymph node metastasis; Palliative treatment; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DOSE RESPONSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67649201891     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cormier JN, Thomas KT, Chari RS, et al: Management of hepatocellular carcinoma. J Gastrointest Surg 2006; 10:761-780.
2. Lo CM, Ngan H, Tso WK, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unre-sectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171.
3. Murakami R, Yoshimatsu S, Yamashita Y, et al: Tran-scatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Acta Radiol 1994; 35:576-580.
4. Murakami R, Yoshimatsu S, Yamashita Y, et al: Treatment of hepatocellular carcinoma: Value of percutaneous microwave coagulation. AJR Am J Roentgenol 1995; 164:1159-1164.
5. Tateishi R, Shiina S, Teratani T, et al: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201-1209.
6. Natsuizaka M, Omura T, Akaike T, et al: Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781-1787.
7. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.
8. Yuki K, Hirohashi S, Sakamoto M, et al: Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990; 66:2174-2179.
9. Schoniger-Hekele M, Muller C, Kutilek M, et al: Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001; 48:103-109.
10. Uenishi T, Hirohashi K, Shuto T, et al: The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today 2000; 30:892-895.
11. Uenishi T, Hirohashi K, Tanaka H, et al: A surgically treated case of hepatocellular carcinoma with extensive lymph node metastases. Hepatogastroenterology 2000; 47:1714-1716.
12. Toya R, Murakami R, Baba Y, et al: Conformal radiation therapy for portal vein tumor thrombosis of hepatocel-lular carcinoma. Radiother Oncol 2007;84:266-271.
13. Dawson LA, Ten Haken RK, Lawrence TS: Partial irradiation of the liver. Semin Radiat Oncol 2001; 11:240-246.
14. Seong J, Park HC, Han KH, et al: Clinical results and prognostic factors in radiotherapy for unresectable hepato-cellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55:329-336.
15. Park HC, Seong J, Han KH, et al: Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002; 54:150-155.
16. Yoon SM, Kim JH, Choi EK, et al: Radioresponse of hepatocellular carcinoma-treatment of lymph node metastasis. Cancer Res Treat 2004;36:79-84.
17. Zeng ZC, Tang ZY, Fan J, et al: Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys 2005; 63:1067-1076.
18. Park YJ, Lim do H, Paik SW, et al: Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Gastroenterol 2006; 41.1099-1106.
19. Yamashita H, Nakagawa K, Shiraishi K, et al: Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: Retrospective study. J Gastroenterol Hepatol 2007;22:523-527.
20. Cheng JC, Chuang VP, Cheng SH, et al: Local radiotherapy with or without transcatheter arterial chemoem-bolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2000; 47:435-442.
21. Seong J, Park HC, Han KH, et al: Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000; 47:1331-1335.
22. Abe T, Furuse J, Yoshino M, et al: Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis. Am J Clin Oncol 2002; 25:318-323.